Which has grown faster, CRL or ZBH?

Over the past five years, CRL grew revenue faster — CRL at a 4.08% CAGR versus ZBH at 2.89%.

Does CRL or ZBH pay a bigger dividend?

ZBH pays a dividend (0.95% yield), while CRL has no payments in the available dividend history.

Is CRL or ZBH more profitable?

ZBH runs the higher net margin — CRL at -5.96% versus ZBH at 9.48%.

How have CRL and ZBH total returns compared?

Over the past 10 years, CRL delivered 13.38% and ZBH delivered -1.25% annualized total return. Past performance doesn't predict future results.

Charles River Laboratories International, Inc. (CRL) vs Zimmer Biomet Holdings, Inc. (ZBH)

A side-by-side comparison of Charles River Laboratories International, Inc. and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

CRL

Charles River Laboratories International, Inc.

$13.97B

$290.00HealthcareAt close: Aug 19, 2026, 4:00 PM ET

ZBH

Zimmer Biomet Holdings, Inc.

$19.49B

$100.74HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — CRL vs ZBH

growth of $100 · dividends reinvested · last 10y

CRL +254.0% (+13.5%/yr)ZBH -11.8% (-1.2%/yr)CRL compounded faster over this window

CRL ZBH

CRL vs ZBH: by the numbers

•ZBH is the larger company ($19.49B vs $13.97B market cap).
•ZBH is profitable (9.48% net margin) while CRL runs a net loss (-5.96%).
•CRL grew revenue faster over the past five years (4.08% vs 2.89% CAGR).
•ZBH pays a dividend (0.95% yield), while CRL has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CRL	ZBH
P/E ratio	N/A	24.51
Forward P/E	25.90	11.81
P/S ratio	3.52	2.28
P/B ratio	4.95	1.54
EV / EBITDA	21.34	11.33
FCF yield	2.64%	9.43%

Profitability

Metric	CRL	ZBH
Gross margin	32.24%	61.62%
Operating margin	12.35%	15.73%
Net margin	-5.96%	9.48%
ROE	-8.40%	6.39%
ROIC	7.72%	5.51%

Dividends

Metric	CRL	ZBH
Dividend yield	N/A	0.95%
Payout ratio	N/A	26.97%

Growth (annualized)

Metric	CRL	ZBH
Revenue CAGR (5Y)	4.08%	2.89%
EPS CAGR (5Y)	-47.86%	N/A
FCF CAGR (5Y)	6.43%	6.49%
Total return CAGR (5Y)	-7.16%	-5.54%

Frequently asked

Which has grown faster, CRL or ZBH?: Over the past five years, CRL grew revenue faster — CRL at a 4.08% CAGR versus ZBH at 2.89%.
Does CRL or ZBH pay a bigger dividend?: ZBH pays a dividend (0.95% yield), while CRL has no payments in the available dividend history.
Is CRL or ZBH more profitable?: ZBH runs the higher net margin — CRL at -5.96% versus ZBH at 9.48%.
How have CRL and ZBH total returns compared?: Over the past 10 years, CRL delivered 13.38% and ZBH delivered -1.25% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CRL analysis Full ZBH analysis Interactive comparison tool

Dig into the metrics

Zimmer Biomet P/E ratio Zimmer Biomet dividend yield Charles River Laboratories International ROE Zimmer Biomet ROE Charles River Laboratories International operating margin Zimmer Biomet operating margin Charles River Laboratories International revenue growth Zimmer Biomet revenue growth Charles River Laboratories International free cash flow Zimmer Biomet free cash flow

Charles River Laboratories International & Zimmer Biomet appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.